Our editors are committed to continuing the efforts that were started by Phil Schwartzkroin and Simon Shorvon to raise the impact factor of Epilepsia. They are very aware of the important role the journal has in helping the League to fulfill its mission to educate and to disseminate new information about epilepsy to the international community and to serve as a forum for the exchange of new ideas. While focused on maintaining the current standards and mission, the incoming editors also emphasize that the publishing landscape for science and medicine is rapidly changing as more material is becoming readily available on the web. To ensure that Epilepsia and the League continue as the authoritative voice for epilepsy care and research, they intend to have broad representation on the editorial board and among the associate editors of the many areas of expertise that are involved in epilepsy and will explore new methods for making important new material more broadly and quickly available.
Astrid Nehlig is a research director at the INSERM facility in Strasbourg, France where she has worked for over 20 years after receiving her degrees at the University of Nancy. She has had a highly productive research career, combining interests of developmental neurobiology, in vivo imaging, pharmacology and epilepsy, and she is widely recognized for her work in neuroimaging in animal models of epilepsy. She is well acquainted with the activities of the League, having served as the co-chair of the Neurobiology Commission during the 2009-2013 term. She has extensive experience with scientific journals serving on the editorial boards of three journals and as a reviewer for over 20 journals that cover a wide spectrum of basic and clinical research.
Michael Sperling is a professor of neurology at Thomas Jefferson University in Philadelphia, Pennsylvania, where he has been on faculty since 1997. His research focus has been in epilepsy and clinical neurophysiology and he has conducted investigations in the electrophysiology of seizures, electrophysiology of cognition, genetics of epilepsy, outcomes of epilepsy treatment, and experimental therapeutics. His clinical focus is on the treatment of refractory epilepsy, with particular attention to epilepsy surgery. Dr. Sperling has been president of the American Clinical Neurophysiology Society, the Philadelphia Neurological Society, and is active in the American Epilepsy Society. He currently serves the League in the surgical therapies commission. He has extensive experience with scientific journals as has served as editorial board member and reviewer for many journals.
Subscribe to the ILAE Newsletter
To subscribe, please provide your email address.